Biomaterial and Stem Cells in Regenerative Medicine

Abstract

Regenerative medicine based on the capacity to restore the structure and function of damaged skin, is estimated to have a worldwide market of US $ 500 billion, according to the US Department of Health and Human Services. To develop regenerative medicine technologies, the most promising emergent sources appear to be stem cells harvested from newborn discarded tissues, from amniotic fluid and tissue, placenta and UC stroma. These sources, in fact, may provide benefits similar to that of the umbilical cord hematopoietic stem cells (UC-HSCs) particularly lack of immune-rejection and ability to bank cells prospectively. This book, consisting of 25 Chapters, describes the up today work performed to offer suitable cell scaffolds and substrates for tissue repair; moreover it addresses the range of different types of applications for which biomaterials and stem cells therapy can be utilized.